Amir Taghavi, B.; Alizadeh, N.; Saeedi, H.; Karim Ahangar, N.; Derakhshani, A.; Hajiasgharzadeh, K.; Silvestris, N.; Baradaran, B.; Brunetti, O.
Targeted Therapy of B7 Family Checkpoints as an Innovative Approach to Overcome Cancer Therapy Resistance: A Review from Chemotherapy to Immunotherapy. Molecules 2022, 27, 3545.
https://doi.org/10.3390/molecules27113545
AMA Style
Amir Taghavi B, Alizadeh N, Saeedi H, Karim Ahangar N, Derakhshani A, Hajiasgharzadeh K, Silvestris N, Baradaran B, Brunetti O.
Targeted Therapy of B7 Family Checkpoints as an Innovative Approach to Overcome Cancer Therapy Resistance: A Review from Chemotherapy to Immunotherapy. Molecules. 2022; 27(11):3545.
https://doi.org/10.3390/molecules27113545
Chicago/Turabian Style
Amir Taghavi, Bita, Nazila Alizadeh, Hossein Saeedi, Noora Karim Ahangar, Afshin Derakhshani, Khalil Hajiasgharzadeh, Nicola Silvestris, Behzad Baradaran, and Oronzo Brunetti.
2022. "Targeted Therapy of B7 Family Checkpoints as an Innovative Approach to Overcome Cancer Therapy Resistance: A Review from Chemotherapy to Immunotherapy" Molecules 27, no. 11: 3545.
https://doi.org/10.3390/molecules27113545
APA Style
Amir Taghavi, B., Alizadeh, N., Saeedi, H., Karim Ahangar, N., Derakhshani, A., Hajiasgharzadeh, K., Silvestris, N., Baradaran, B., & Brunetti, O.
(2022). Targeted Therapy of B7 Family Checkpoints as an Innovative Approach to Overcome Cancer Therapy Resistance: A Review from Chemotherapy to Immunotherapy. Molecules, 27(11), 3545.
https://doi.org/10.3390/molecules27113545
